Business Context and Reporting Period
Company: Alkermes Plc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 7, 2012
Event: Entry into a Material Definitive Agreement and Regulation FD Disclosure regarding a registered offering of shares held by a major shareholder.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate transaction involving share transfers.
Material Changes and Transaction Details
- Waiver and Consent: On March 7, 2012, Alkermes executed a Waiver and Consent Letter regarding the Shareholder's Agreement dated September 16, 2011, with Elan Corporation, plc (Shareholder Parent) and Elan Science Three Limited (Shareholder).
- Restriction Waiver: The Company waived limitations prohibiting the transfer of shares held by the Shareholder prior to the six-month anniversary of the Closing Date and limits on transferring more than 40.75% of shares in a registered offering.
- Share Transfer Authorization: The Company consented to the transfer of up to 15,985,000 ordinary shares by the Shareholder in a Registered Offering (Form S-1, File No. 333-179550).
- Offering Commencement: The Company announced the commencement of the Registered Offering of 13,900,000 ordinary shares held by the Shareholder, subject to market conditions.
- Over-Allotment Option: The Shareholder intends to grant underwriters a 30-day option to purchase up to an additional 2,085,000 ordinary shares.
- Impact on Company: Alkermes will not receive any proceeds from this offering, and the total number of outstanding shares will not change.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the offering is subject to market and other conditions. The primary contingency noted is the successful execution of the Registered Offering by the Shareholder.
Investor Verification Checklist
- Verify the final number of shares sold in the Registered Offering and the exercise of the 30-day over-allotment option.
- Confirm the sale price per share and total proceeds received by the Shareholder (Elan Science Three Limited).
- Review the updated beneficial ownership percentage of Elan Corporation, plc following the transaction.
- Check subsequent filings for any changes to the Shareholder's Agreement or additional waivers.